Monoclonal Antibody Medicine - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2757518
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 145
-
According to Ample Market Research, the global market for Monoclonal Antibody Medicine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Monoclonal Antibody Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Monoclonal Antibody Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Cancer grew percent to account for percent of the total market sales, and Autoimmune Disease grew percent.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies and analyses global Monoclonal Antibody Medicine status and future trends, to help determine the Monoclonal Antibody Medicine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Monoclonal Antibody Medicine, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Monoclonal Antibody Medicine market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Monoclonal Antibody Medicine by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Monoclonal Antibody Medicine by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Monoclonal Antibody Medicine key consuming regions, consumption value and demand structure
(5) Monoclonal Antibody Medicine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Market segment by Type, covers
Biologics
Biosimilars
Market segment by Application, can be divided into
Cancer
Autoimmune Disease
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Monoclonal Antibody Medicine product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Monoclonal Antibody Medicine market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Monoclonal Antibody Medicine market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Monoclonal Antibody Medicine industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Monoclonal Antibody Medicine Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Monoclonal Antibody Medicine Definition
1.2 Global Monoclonal Antibody Medicine Market Size and Forecast
1.3 China Monoclonal Antibody Medicine Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Monoclonal Antibody Medicine Market Size: China VS Global Growth Rate, 2018-2029
1.6 Monoclonal Antibody Medicine Market Dynamics
1.6.1 Monoclonal Antibody Medicine Market Drivers
1.6.2 Monoclonal Antibody Medicine Market Restraints
1.6.3 Monoclonal Antibody Medicine Industry Trends
1.6.4 Monoclonal Antibody Medicine Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Monoclonal Antibody Medicine, Global Market Share by Company, 2018-2023
2.2 Global Monoclonal Antibody Medicine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Monoclonal Antibody Medicine Concentration Ratio
2.4 Global Monoclonal Antibody Medicine Mergers & Acquisitions, Expansion Plans
2.5 Global Monoclonal Antibody Medicine Major Companies Product Type
2.6 Head Office and Monoclonal Antibody Medicine Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Monoclonal Antibody Medicine, China Market Share by Company, 2018-2023
3.2 China Monoclonal Antibody Medicine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Monoclonal Antibody Medicine Industry Chain
4.2 Monoclonal Antibody Medicine Upstream Analysis
4.2.1 Monoclonal Antibody Medicine Core Raw Materials
4.2.2 Main Manufacturers of Monoclonal Antibody Medicine Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Monoclonal Antibody Medicine Production Mode
4.6 Monoclonal Antibody Medicine Procurement Model
4.7 Monoclonal Antibody Medicine Industry Sales Model and Sales Channels
4.7.1 Monoclonal Antibody Medicine Sales Model
4.7.2 Monoclonal Antibody Medicine Typical Distributors
5 Sights by Type5.1 Monoclonal Antibody Medicine Classification
5.1.1 Biologics
5.1.2 Biosimilars5.2 By Type, Global Monoclonal Antibody Medicine Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Monoclonal Antibody Medicine Consumption Value, 2018-2029
6 Sights by Application6.1 Monoclonal Antibody Medicine Segment by Application
6.1.1 Cancer
6.1.2 Autoimmune Disease
6.1.3 Other6.2 By Application, Global Monoclonal Antibody Medicine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Monoclonal Antibody Medicine Consumption Value, 2018-2029
7 Sales Sights by Region7.1 By Region, Global Monoclonal Antibody Medicine Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Monoclonal Antibody Medicine Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Monoclonal Antibody Medicine & Forecasts, 2018-2029
7.3.2 By Country, North America Monoclonal Antibody Medicine Market Size Market Share7.4 Europe
7.4.1 Europe Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Monoclonal Antibody Medicine Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Monoclonal Antibody Medicine Market Size Market Share7.6 South America
7.6.1 South America Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Monoclonal Antibody Medicine Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Monoclonal Antibody Medicine Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Monoclonal Antibody Medicine Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Monoclonal Antibody Medicine Market Size, 2018-2029
8.3.2 By Type, U.S. Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 20298.4 Europe
8.4.1 Europe Monoclonal Antibody Medicine Market Size, 2018-2029
8.4.2 By Type, Europe Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 20298.5 China
8.5.1 China Monoclonal Antibody Medicine Market Size, 2018-2029
8.5.2 By Type, China Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 20298.6 Japan
8.6.1 Japan Monoclonal Antibody Medicine Market Size, 2018-2029
8.6.2 By Type, Japan Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Monoclonal Antibody Medicine Market Size, 2018-2029
8.7.2 By Type, South Korea Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Monoclonal Antibody Medicine Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Monoclonal Antibody Medicine Market Size, 2018-2029
8.9.2 By Type, India Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 20298.10 Middle East & Africa
8.10.1 Middle East & Africa Monoclonal Antibody Medicine Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Monoclonal Antibody Medicine Consumption Value Market Share, 2022 VS 2029
9 Company Profile9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Monoclonal Antibody Medicine Models, Specifications and Application
9.1.4 Roche Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Monoclonal Antibody Medicine Models, Specifications and Application
9.2.4 Amgen Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Monoclonal Antibody Medicine Models, Specifications and Application
9.3.4 AbbVie Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Monoclonal Antibody Medicine Models, Specifications and Application
9.4.4 Sanofi Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Monoclonal Antibody Medicine Models, Specifications and Application
9.5.4 Johnson & Johnson Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Monoclonal Antibody Medicine Models, Specifications and Application
9.6.4 Pfizer Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Eli Lilly
9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.7.2 Eli Lilly Company Profile and Main Business
9.7.3 Eli Lilly Monoclonal Antibody Medicine Models, Specifications and Application
9.7.4 Eli Lilly Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.7.5 Eli Lilly Recent Developments
9.8 Novartis
9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.8.2 Novartis Company Profile and Main Business
9.8.3 Novartis Monoclonal Antibody Medicine Models, Specifications and Application
9.8.4 Novartis Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.8.5 Novartis Recent Developments
9.9 Merck
9.9.1 Merck Company Information, Head Office, Market Area and Industry Position
9.9.2 Merck Company Profile and Main Business
9.9.3 Merck Monoclonal Antibody Medicine Models, Specifications and Application
9.9.4 Merck Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.9.5 Merck Recent Developments9.10 Biogen
9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.10.2 Biogen Company Profile and Main Business
9.10.3 Biogen Monoclonal Antibody Medicine Models, Specifications and Application
9.10.4 Biogen Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.10.5 Biogen Recent Developments
9.11 Celltrion
9.11.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.11.2 Celltrion Company Profile and Main Business
9.11.3 Celltrion Monoclonal Antibody Medicine Models, Specifications and Application
9.11.4 Celltrion Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.11.5 Celltrion Recent Developments
9.12 Sobi
9.12.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.12.2 Sobi Company Profile and Main Business
9.12.3 Sobi Monoclonal Antibody Medicine Models, Specifications and Application
9.12.4 Sobi Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.12.5 Sobi Recent Developments
9.13 3SBIO
9.13.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.13.2 3SBIO Company Profile and Main Business
9.13.3 3SBIO Monoclonal Antibody Medicine Models, Specifications and Application
9.13.4 3SBIO Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.13.5 3SBIO Recent Developments
9.14 Innovent Biologics
9.14.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.14.2 Innovent Biologics Company Profile and Main Business
9.14.3 Innovent Biologics Monoclonal Antibody Medicine Models, Specifications and Application
9.14.4 Innovent Biologics Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023
9.14.5 Innovent Biologics Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Monoclonal Antibody Medicine Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Monoclonal Antibody Medicine Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Monoclonal Antibody Medicine Global and China Top Players has a wide range of applications, including
The Monoclonal Antibody Medicine Global and China Top Players Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The influx of capital into the Monoclonal Antibody Medicine Global and China Top Players Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
During the forecast years, the Monoclonal Antibody Medicine Global and China Top Players Market can thrive with a robust CAGR.
